A study looked at 400 people who had opioid use disorder along with mental health issues like depression or PTSD. The goal was to see how many patients received medication or counseling during a six-month period of collaborative care.
Results showed that about half of the patients received psychiatric medication, while about 44% received counseling. However, some people faced more hurdles. For example, patients who also used stimulants were less likely to get medication or counseling. People with lower levels of education also faced a harder time getting these services.
Other factors influenced care. Men were less likely to receive counseling, while people of non-Hispanic ethnicity were more likely to get it. Patients with more severe symptoms of depression and PTSD were more likely to receive counseling. These findings help doctors see who might need extra support to get the care they need.
Common questions
What were the main findings regarding treatment access?
In a study of 400 patients with opioid use disorder, 51% received psychiatric medication and 44% received counseling over six months. The study highlighted that certain factors, such as lower education levels or the co-use of stimulants, were associated with a lower likelihood of receiving these essential mental health services.
How did other factors like sex or symptoms affect care?
The study found that men were less likely to receive counseling. In contrast, patients with more severe depression and PTSD symptoms were more likely to receive counseling. Non-Hispanic patients were also found to have a greater likelihood of receiving counseling during the study period.
What role did stimulant use play in the results?
The data showed that the co-use of stimulants was associated with a lower likelihood of receiving both psychiatric medication and counseling. These findings suggest that certain patient profiles may face more barriers to accessing care in collaborative settings.
